Furthermore, in our previous work with MS patients from Croatian and Slovenian populations, we demonstrated that the homozygous ACE‐DD genotype might contribute to an elevated MS risk among male patients (Lovrečić et al., 2006). This evidence concerns the gene ACE and myeloid sarcoma.